Ratings by Jefferies (Amin Makarem)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/9/2026 | UroGen Pharma | URGN | New Coverage | Buy (N/A) |
19.10 (36.07) |
88.85% | Details | |
| 3/12/2026 | Foghorn Therapeutics | FHTX | Maintain | Buy (N/A) |
|
Details | ||
| 2/17/2026 | Foghorn Therapeutics | FHTX | New Coverage | Buy (N/A) |
5.26 (4.86) |
-7.6% | Details | |
| 2/17/2026 | Cellectis | CLLS | New Coverage | Buy (N/A) |
3.49 (2.94) |
-15.76% | Details |
